SeeBITDAOklahoma

Keyes' Compounding & Specialty Drug, LLC

All Other Professional, Scientific, and Technical Services
  • 1602 SW 3RD ST, Elk City, OK
  • Since 2017
Estimated valueLow confidence
$1.3M
$637Klikely range$1.9M
About 3× its yearly profit, typical for a company this size in its industry.
Revenue
$2.5M
a year
Profit (EBITDA)
$448K
18% of revenue
Employees
7
reported in 2020
Owner not found yet
We haven't found the owner in public records

How we got $1.3M

Based on 7 employees reported for PPP in 2020, grown at the industry's Oklahoma rate since.

7 employees × $302K each$2.1M
Shown toward the top of its range×1.18
Revenue$2.5M
× 18% profit margin$448K
× 3 sale multiple = value$1.3M

· Own this business? Correct these figures

What we know

PPP loan, 2020
No 401(k) filing
No reported financials
Company website
Owner not found

Estimated value over time

▼ 13% since 2020
$0$888K$1.8M20202026

Today's estimate scaled by the headcount reported each year and that year's prices. A trend, not a record of past sale values.

Compared with similar businesses nearby

BusinessEst. revenueEst. profitDistance
KEYES' COMPOUNDING & SPECIALTY DRUG, LLC
this business
$2.5M$448K—
Stockmans Veterinary Clinic
Elk City
$1.2M$242K1.3 mi
WESTERN ANIMAL HOSPITAL, INC.
Elk City · 3 employees
$1.1M$214K1.8 mi
TWISTED C CONSULTING, LLC
Elk City · 1 employees
$616K$143K1.8 mi
Elk Creek Animal Clinic
Elk City
$1.2M$242K2.0 mi
CIRCLE M ANIMAL HOSPITAL, PLLC
Elk City · 10 employees
$2.3M$419K2.2 mi
RED EARTH ANIMAL HOSPITAL AND PET BOARDING P.C.
Elk City · 6 employees
$1.5M$263K3.0 mi

The full calculation

Employees reported to the SBA7
Industry revenue per employee$217K
Revenue = employees × revenue per employee$2.5M
EBITDA margin (industry, adjusted for size)18%
EBITDA = revenue × margin$448K
Cross-check: revenue implied by PPP payroll$525K

Figures are shown toward the upper part of their range rather than at its middle.

Brought up to date assuming revenue has grown 8% a year since 2020, when the PPP figures were reported; included above.

Estimated value = EBITDA × typical sale multiple$1.3M
Multiple for this size and industry3×
Value range$637K – $1.9M
Revenue range$1.5M – $3.0M
EBITDA range$265K – $531K
Industry (NAICS)All Other Professional, Scientific, and Technical Services (541990)

Low confidence: the employee-based and payroll-based estimates differ by more than 2×.

EBITDA margin: from IRS tax returns of S corporations in this industry (2019–2022), adjusted for company size: smaller companies typically run higher margins. EBITDA here is after owners' salaries.

Benchmarks: US Economic Census 2022. PPP loans were sized on 2019–2020 payroll, so figures reflect that period. These are statistical estimates, not reported financials. Full methodology

People & advisors

Advisors

  • BankingThe First National Bank & TrustPPP / SBA lender

From the company's own website and public filings (DOL Form 5500, IRS Form 990, SBA). Roles are as stated there and may be out of date.

Banking relationships

First Bank and Trust Co
PPP 2020
All 694 borrowers →

From PPP and SBA loan records, which name the bank but not the individual banker.

PPP loans

ApprovedDrawAmountForgivenJobsLender
4/4/2020first$19K$19K7The First National Bank & Trust

Public records

Matched to this business by name and address from public government data; a match can occasionally be wrong.

About Keyes' Compounding & Specialty Drug, LLC

Keyes' Compounding & Specialty Drug, LLC is an all other professional, scientific, and technical services company in Elk City, Oklahoma, in business since 2017. Its estimated annual revenue is about $2.5M, with roughly $448K of EBITDA. It has about 7 employees. Its estimated business value is $1.3M (likely range $637K–$1.9M).

Common questions

Who owns Keyes' Compounding & Specialty Drug, LLC?
The owner of Keyes' Compounding & Specialty Drug, LLC isn't in public records we've found yet. If you own or run the business, you can add or correct its details on SeeBITDA.
How much revenue does Keyes' Compounding & Specialty Drug, LLC make?
SeeBITDA estimates Keyes' Compounding & Specialty Drug, LLC's annual revenue at about $2.5M (likely between $1.5M and $3.0M), based on public records such as its PPP loan and retirement-plan filings, brought up to 2026.
What is Keyes' Compounding & Specialty Drug, LLC worth?
About $1.3M, roughly 3× its estimated EBITDA of $448K, typical for a all other professional, scientific, and technical services company its size. Likely range: $637K–$1.9M.
How many employees does Keyes' Compounding & Specialty Drug, LLC have?
About 7, as reported on its PPP loan.
When was Keyes' Compounding & Specialty Drug, LLC founded?
Keyes' Compounding & Specialty Drug, LLC has been in business since 2017.